In our study, we detected 17 immune-related markers inside the tumor of HCC patients, then we found CD44, CD20, CD68, HLA-DR, and CD31 as the prognosis-related markers using LASSO Cox regression model. This evidence concerns the gene PECAM1 and neoplasm.